For the treatment of mutations related to the diffusion disorder of variant FLT3

• 收藏
• 分享

专利权人:

AROG PHARMACEUTICALS; INC.

发明人:

JAIN, Vinay K.

申请号：

PE2019000923

公开号：

PE20191238A1

申请日:

2017.10.31

申请国别(地区):

PE

年份:

2019

代理人:

摘要：

It refers to the use of clonidine in the form of a pharmaceutically acceptable salt for the treatment of one or more diffusive disorders of mutations of thyroid hormone quinase virus related to FMS 3 (F3).Referido al uso de crenolanib en forma de sal farmaceuticamente aceptable para el tratamiento de uno o mas trastornos proliferativos caracterizados por mutaciones en vias de tirosina quinasa relacionada con FMS 3 (FLT3).

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/